The PITRM1 gene helps mitochondria, the parts of cells that make energy, clear away small protein fragments after proteins are brought inside. If it does not work properly, these fragments can build up, strain energy production, and affect tissues with high energy needs, especially the brain and muscles. The protein made by this gene helps your cells keep mitochondria working smoothly. Pathogenic variants in both copies of the PITRM1 gene are linked to a rare inherited mitochondrial condition that may involve developmental delay, poor balance, seizures, or muscle weakness.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes carry the information needed to make proteins, the working parts of cells. Others mainly help direct when certain processes happen, where they take place, and how strongly they operate. Taken together, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
PITRM1Gene function
What if the gene works
The PITRM1 gene helps mitochondria, the cell’s energy centers, break down small leftover protein pieces. This supports protein balance inside mitochondria and helps them keep working properly.
Risk
What if the gene does not work
When the PITRM1 gene does not work properly, a mitochondrial brain condition can develop, often causing balance and walking problems with speech or cognitive decline. Milder and more severe variants may change when symptoms start and how marked they become.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the PITRM1 gene, no PITRM1-specific treatment or drug choice approach is currently established in clinical guidelines. Management is based on the person’s symptoms rather than the gene itself. The PITRM1 gene is being studied in mitochondrial disease and neurodegeneration research, but this has not yet changed routine treatment.
Gene function
What if the gene works
Your cells need healthy mitochondria, the parts that make most of their energy. The PITRM1 gene helps with protein cleanup inside mitochondria after new proteins arrive. This supports steady energy production and everyday cell maintenance.
PITRM1 breaks down small leftover protein pieces inside mitochondria. These pieces are normally released after imported proteins have their delivery tags removed.
By clearing used delivery tags, this gene helps newly arrived proteins settle into the right mitochondrial environment. That supports smooth handling of proteins needed for cell energy production.
PITRM1 also removes other short, loose protein fragments before they collect inside mitochondria. This ongoing housekeeping is part of normal mitochondrial protein quality control and helps cells work smoothly.
What is a variant?
Within a gene, a genetic variant is a small difference in its DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PITRM1 gene affect mitochondrial protein breakdown by weakening or destabilizing the enzyme that clears short protein fragments inside mitochondria, the parts of cells that make energy. Milder variants may leave some enzyme activity, while more severe variants can sharply reduce activity or make the protein unstable so it is broken down too soon. As fragments build up, mitochondria handle proteins less efficiently, and more disruptive variants may be linked to earlier or more marked neurologic disease.
How variants are linked to conditions
Pathogenic variants in the PITRM1 gene can cause a rare inherited mitochondrial condition, often called combined oxidative phosphorylation deficiency 23. People with PITRM1-related disease may have developmental delay, seizures, balance and walking problems, muscle weakness, and gradual changes in thinking or behavior. In affected families, the condition appears when both copies of the PITRM1 gene carry a pathogenic variant. This is the main way PITRM1 gene variants are linked to conditions in current medical genetics.
A variant is not necessarily a diagnosis
Variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the PITRM1 gene. For many living with PITRM1-related changes, risk mainly depends on the exact gene change inherited rather than clear lifestyle or environmental factors, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of PITRM1 variants
PITRM1-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops the condition only if they inherit two disease-causing PITRM1 gene variants, one from each parent. Parents who each carry one PITRM1 gene variant are often healthy carriers, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who does not inherit either variant. This is the established inheritance pattern for PITRM1 gene variants linked to disease.
What does my PITRM1 result mean for my family?
For PITRM1, family implications are usually discussed in terms of a recessive pattern. This often means parents of an affected child are healthy carriers, and brothers or sisters may also be affected or may be carriers. Other close relatives, such as siblings of the parents, may also carry the family variant.
Genetic information
Genetic testing
How you find out about variants
PITRM1 genetic testing usually uses a blood or saliva sample. A lab reads the DNA sequence of the PITRM1 gene to look for variants. This type of test for PITRM1 variants can help clarify whether an inherited gene change is linked to a person’s symptoms or family history.
When should I consider getting a genetic test?
Consider PITRM1 testing if there is a family history of a very rare inherited condition linked to this gene, or if someone has unexplained balance problems, seizures, developmental delay, or loss of skills and doctors suspect an inherited energy-production condition. It can also help clarify carrier status in relatives.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and on the type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. With some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medicine may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. By studying the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how the body processes a drug or how strongly that drug works. This information can support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the PITRM1 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so general health concerns, new symptoms, or medicine side effects are best discussed with your doctor.